Several researchers have also identified a number of molecular genetic variations in IPMNs, some of which are in common with those seen in pancreatic adenocarcinomas, such as the mutations in KRAS, SMAD4, and TP53 genes [35]. This evidence concerns the gene SMAD4 and pancreatic adenocarcinoma.